Portrait of a smiling person with dark hair wearing a patterned top.

Trupti Thite

Information Scientist

Bio

Trupti has a Ph.D. in Cell Biology from the Indian Institute of Science Education and Research (IISER), Pune. She previously gained extensive experience in scientific writing, data curation, and analysis in diverse fields like pharmaceuticals, medical devices, and precision oncology. She combines her deep domain knowledge with scientific reasoning skills to transform complex data into actionable insights.

Digital visualization of a human brain composed of interconnected blue glowing neural network lines and nodes on a dark background.

Psychiatric Drug Discovery: New Targets, Mechanisms, and Opportunities

Treating mental health disorders has involved the same approach for nearly 70 years. Now, researchers are exploring new biological pathways and different potential drug compounds to better address conditions like depression, schizophrenia, and bipolar disorder.
|Article
Read the CAS Insights article
Close-up digital illustration of blue neurons with branching dendrites against a dark background, representing brain neural cells.

Neuroinflammation Driving New Research Into Alzheimer’s and More

Neuroinflammation is a known symptom of diseases like Alzheimer’s, Parkinson’s, and multiple sclerosis, but it’s also a driver in disease progression. This insight is leading to new therapeutic targets to reduce neuroinflammation.
|Article
Read the CAS Insights article
White immune cells attacking a large pink cancer cell on a red tissue surface.

New translational research in immuno-oncology may reach patients who do not respond to current therapies

Immunotherapy is driving precision oncology, but existing immuno-oncology treatments aren’t effective for every patient. Our review of the translational research landscape reveals which targets and therapies are showing promising results in clinical trials.
|Article
Read the CAS Insights article
Colorful antibody molecules binding to a blue textured cell surface.

Innovations in cancer immunotherapy: Bi-specific T cell engagers

Bi-specific T cell engagers are poised to become key immunotherapy treatments due to simpler production and new safety advances.
|Article
Read the CAS Insights article
Red single- and double-stranded RNA helices on a dark background.

New breakthroughs in siRNA therapeutics expand the drug pipeline

Advances in drug development are improving the pipeline of siRNA therapeutics.
|Article
Read the CAS Insights article
Blue neurons with branching dendrites connected above textured orange tissue in a scientific illustration.

Spatial transcriptomics could unlock new treatments for Alzheimer’s, cancer, and more

Spatial transcriptomics provides unprecedented insights into the organization, function, and interactions of cells within complex tissues, allowing a deeper understanding of cellular composition and activity.
|Article
Read the CAS Insights article
Stem cells with pink nuclei surrounded by translucent membranes on a teal background.

Can stem cell therapy cure diabetes?

Conventional diabetes treatment focuses on regulating blood glucose levels, not reducing or treating its complications. But new stem cell therapy strategies could result in more effective and long-lasting treatments.
|Article
Read the CAS Insights article
Red microRNA strands coiled against a dark blue background.

Advancing microRNA therapeutics with new delivery methods

Advances in nanoscale drug delivery systems are addressing current microRNA therapy issues, which may lead to its becoming a more widely leveraged delivery method.
|Article
Read the CAS Insights article
Pipette tip dispensing a droplet onto a surface covered with water beads.

Biomarkers may improve autism diagnosis and care

Learn about research into biomarkers that could provide objective measurements to improve the diagnosis and treatment of Autism Spectrum Disorder (ASD).
|Article
Read the CAS Insights article